Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Vercellotti

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|October 28, 2018
A Simpler Answer - After All This TimeDonna J Coetzee, Gregory Vercellotti, Andrew P J Olson
Cureus|February 3, 2022
A Vanishing Cecal Mass: A Rare Gastrointestinal Manifestation of Systemic MastocytosisKrista Newman, Gregory Vercellotti, Dale Snover, et al.
Dermatologic Therapy|September 18, 2018
Intravenous immunoglobulin for treatment of necrobiotic xanthogranulomaAmrita Goyal, Daniel O'Leary, Gregory Vercellotti, et al.
Cryobiology|October 14, 2010
Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model systemJing Jiang, Raghav Goel, Stephen Schmechel, et al.
Antioxidants & Redox Signaling|August 25, 2009
Heme degradation and vascular injuryJohn D Belcher, Joan D Beckman, Gyorgy Balla, et al.
Laboratory Medicine|September 12, 2016
Clonal Lymphoproliferations in a Patient With Common Variable ImmunodeficiencySarah A Williams, Laura E Moench, Fatima Khan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2016
Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemiaJonathan D Alpern, Sophie S Arbefeville, Gregory Vercellotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2018
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-UpErica Dahl Warlick, Todd E DeFor, Nelli Bejanyan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/MethotrexateNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2010
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomasErica D Warlick, Marcie Tomblyn, Qing Cao, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|October 28, 2018
A Simpler Answer - After All This TimeDonna J Coetzee, Gregory Vercellotti, Andrew P J Olson
Cureus|February 3, 2022
A Vanishing Cecal Mass: A Rare Gastrointestinal Manifestation of Systemic MastocytosisKrista Newman, Gregory Vercellotti, Dale Snover, et al.
Dermatologic Therapy|September 18, 2018
Intravenous immunoglobulin for treatment of necrobiotic xanthogranulomaAmrita Goyal, Daniel O'Leary, Gregory Vercellotti, et al.
Cryobiology|October 14, 2010
Pre-conditioning cryosurgery: cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model systemJing Jiang, Raghav Goel, Stephen Schmechel, et al.
Antioxidants & Redox Signaling|August 25, 2009
Heme degradation and vascular injuryJohn D Belcher, Joan D Beckman, Gyorgy Balla, et al.
Laboratory Medicine|September 12, 2016
Clonal Lymphoproliferations in a Patient With Common Variable ImmunodeficiencySarah A Williams, Laura E Moench, Fatima Khan, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2016
Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemiaJonathan D Alpern, Sophie S Arbefeville, Gregory Vercellotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2018
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-UpErica Dahl Warlick, Todd E DeFor, Nelli Bejanyan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/MethotrexateNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2010
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomasErica D Warlick, Marcie Tomblyn, Qing Cao, et al.
Pageof 2